Latest Annual General Meeting News

FleetPartners Group Limited reported a robust 13% increase in adjusted EPS for FY24, propelled by targeted market growth, operational transformation, and a disciplined share buy-back program. The company remains optimistic about sustaining momentum despite a modest dip in new business writings in early FY25.

FleetPartners Group Limited reported strong FY24 results with record new business writings and assets under management, underpinning a robust growth trajectory and a significant $30 million share buy-back announced for 1H25.

FleetPartners Group Limited reported a strong FY24 with record new business writings and a significant capital return, underscoring its disciplined growth and ESG commitments.

Resource Base Limited reports a solid cash position of $1.06 million and ongoing lithium exploration progress at its Wali and Ernst Lake projects in Quebec, alongside rare earth element developments in Australia.

Zeus Resources has successfully placed the shortfall in its Priority Options Offer, bringing total funds raised to nearly $200,000. The move reflects solid shareholder backing ahead of the company’s next growth phase.

Murray Cod Australia Limited has announced a 10-for-1 security consolidation affecting all ordinary shares and options, aiming to simplify its capital structure ahead of resumed trading in February 2025.

MetalsGrove Mining Limited reports promising exploration results with four new gold-copper prospects identified at its Bruce Project and significant zinc-copper-lead mineralisation confirmed at Edwards Creek, underpinning its 2025 exploration plans.

Basin Energy has completed its acquisition of a promising uranium and green energy metals portfolio in Scandinavia, marking a significant expansion into a historically overlooked region. The move positions the company to leverage emerging opportunities in the Nordic green energy sector.

Anatara Lifesciences has successfully completed recruitment for the second stage of its pivotal GaRP-IBS clinical trial, with headline results expected in Q1 2025. The company also launched a new anti-obesity project and strengthened its cash position through recent capital raises.